The Capsule Endoscopes market size is expected to reach US$ 1,398.63 million by 2031 from US$ 826.45 million in 2024. The market is estimated to record a CAGR of 7.8% from 2025 to 2031.
The global Candidiasis Drugs Market was valued at USD 3.5 billion in 2024 and is estimated to reach USD 6.2 billion by the end of 2037, expanding at a compound annual growth rate (CAGR) of 5.1% during the forecast timeline. This growth reflects increasing awareness, improved diagnostic practices, and the rising prevalence of fungal infections driven by aging populations, immune-compromised conditions, and hospital-acquired infections.
Candidiasis Drugs Industry Demand
Precision Business Insights has published a report on the global medical polyoxymethylene market, estimating its value at USD 235.4 Million in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 4.5% over the forecast period 2025-2031. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.
The global Personal Hygiene Market The was valued at USD 550.6 billion in 2024 and is projected to surpass USD 850.8 billion by 2037, expanding at a CAGR of over 4.4%. Market growth is driven by rising hygiene consciousness, evolving wellness lifestyles, and ongoing product innovation.
Personal Hygiene Industry Demand
The India Industrial Lubricant Market is undergoing a significant transformation, projected to grow at a steady CAGR of 4.28% through 2030. Currently valued at USD 7.25 billion in 2024, this growth trajectory is supported by multiple factors including rapid industrialization, technological advancements in lubrication solutions, and increasing emphasis on sustainable manufacturing practices.
In highly sensitive industrial environments such as petrochemical plants, nuclear power stations, and pharmaceutical processing units, valve integrity and emission control are critical. External Stem Bellow Seal Globe and Gate Valves are engineered specifically to meet these demands, offering absolute sealing performance, zero stem leakage, and long operational life.
Precision Business Insights has published a report on the global CBRN and ballistic protection market, estimating its value at USD 7,300 Million in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 5.0% over the forecast period 2025-2031. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.
The global Rheumatoid Arthritis Treatment Market was valued at USD 35.75 billion in 2024 and is projected to surpass USD 77.19 billion by 2037, expanding at a compound annual growth rate (CAGR) of over 6.1% during the forecast period. This consistent growth is driven by advancements in biologics, increasing incidence of autoimmune diseases, and growing awareness among patients about early diagnosis and management.
Rheumatoid Arthritis Treatment Industry Demand
Sagar Steel Corporation, is one of the leading Pipes and Tubes Manufacturers in India, understands the critical role these products play across industries. Our commitment to quality, precision, and performance makes us a trusted name in the market.
In today’s industrial landscape, Pipes and Tubes are more than just components; they are the fast-evolving building blocks of infrastructure, manufacturing, and engineering systems. From transporting fluids and gases to supporting structural frameworks, these cylindrical powerhouses are everywhere.
Wide Range of Products
Starting a business in the healthcare industry is a smart move—especially in 2025, when the demand for quality medicines is increasing day by day. One of the most successful and affordable ways to enter this growing field is by starting a PCD Pharma Franchise.
Whether you're new to the business world or have experience in pharma sales or distribution, this model offers a stable path to growth with limited risk.
